MISX
LVHK
Market cap14mUSD
Oct 08, Last price
23.70RUB
1D
2.91%
1Q
-28.05%
Jan 2017
145.83%
IPO
26.07%
Name
Levenguk OAO
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Levenhuk Inc. specializes in the production and global distribution of a diverse range of optical devices and scientific instruments. Their comprehensive product line features telescopes, microscopes, binoculars, spotting scopes, magnifiers, and monoculars, alongside a variety of related accessories. The company further provides ready-to-use microscope slides, celestial observation charts, specialized cleaning supplies for optics, and educational materials pertaining to natural sciences. Operating primarily under its proprietary Levenhuk brand, the firm, which was established in 2002 and is headquartered in Tampa, Florida, serves customers through an extensive dealer network across the United States, Canada, India, Azerbaijan, Uzbekistan, Southeast Asia, and throughout Europe.
Key people
Anton Epifanov
General Director (CEO), Director · since 2012
Kristina Uryakina
Secretary to the Board of Directors · since 2016
Aleksandr Egorov
Deputy Chairman of the Board · since 2013
Aleksandr Ivanov
Director · since 2016
Tatyana Krylova
Chairwoman of the Board · since 2016
Aleksandr Shekhonin
Director · since 2012
Valuation
Title RUB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||